Curis Lifesciences Limited IPO
Curis Lifesciences Limited IPO
Curis Lifesciences Limited IPO
₹ 256000 / 2000 Shares Shares
Minimum Investment
Curis Lifesciences Limited IPO
Issues Price
₹120-128 per equity share
Curis Lifesciences Limited IPO
Open Date
07 Nov 2025
Close Date
11 Nov 2025
Lot Size
1000
Min. Investment
₹ 256000
Issue Price
₹120-128
Listing Date
14 Nov 2025
Issues Size
21,50,000 shares(aggregating up to ₹27.52 crore)
Face Value
₹10 Per Equity Share
Total Shares Offered
2000 Shares
Offered To Public
2000 Shares
Curis Lifesciences Limited IPO
Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.
Founded In
2020
Managing Director
Dharmesh Dasharathbhai Patel
Parent Organization
Curis Lifesciences Limited IPO
Application for Curis Lifesciences Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Individual (min) | ₹120-128 | ₹2,56,000 |
| Individual(max) | ₹120-128 | ₹2,56,000 |
| SHNI(min) | ₹120-128 | ₹3,84,000 |
| SHNI(max) | ₹120-128 | ₹8,96,000 |
| BHNI(min) | ₹120-128 | ₹10,24,000 |
Apply for all eligible candidates, Curis Lifesciences Limited IPO.
Testimonial
Genuine Review Form Statisifed Customers
KSquare’s New Fund Offering updates are timely and insightful. I’ve participated in two NFOs already, and the results have been quite impressive and transparent.
KSquare’s service was fast, transparent, and easy to follow. Perfect for someone like me who needed quick access to funds.
KSquare provided all the guidance I needed to start SIPs. Their plans fit my freelance income, and I’m seeing real results already!
It’s rare to find an investing service that explains NFOs in such a relatable way. KSquare really bridges that gap. Very impressed!
KSquare stands out with their personalized approach to NRI investing. Their team’s insights and professionalism are unmatched.
Living in Europe, I missed investing in India. KSquare filled that gap with an easy-to-use, trustworthy service. Love it!
KSquare’s guidance was top-tier. I felt informed and in control during the entire loan process. Truly reliable.
KSquare’s NRI Corner made investing from abroad incredibly simple. The guidance was crystal clear, and their support team always kept me informed. Highly recommend this service for all NRIs!
Investing used to feel complicated, but KSquare’s SIP process made it simple and stress-free. Now I save monthly without thinking twice.
I found KSquare’s NFO guides super user-friendly. They cover risks and benefits without overwhelming new investors. Highly recommended for anyone starting out.
FAQ's
Frequenlty Asked Question
Are SIP investments safe?
While SIPs are subject to market risks, long-term investing and diversification help reduce risk and improve returns.
Is NPS a market-linked investment?
Yes, NPS invests in equity and debt instruments, so returns vary with market performance over time.
What fees or charges are involved in mutual fund investing?
Mutual funds may have expense ratios and exit loads. KSquare discloses all charges clearly before you invest.
Are NFOs better suited for long-term investors?
NFOs are ideal for long-term investors who can wait for the fund to build performance and portfolio over time.
How does KSquare ensure compliance with FEMA rules?
KSquare’s advisory follows all FEMA guidelines, helping NRIs invest safely while staying compliant with Indian regulations.
Can I have multiple SIPs for different goals?
Yes, you can set up multiple SIPs with KSquare for various goals like retirement, education, or buying a home.
How does KSquare select and list New Fund Offerings?
KSquare features only SEBI-registered, vetted NFOs and provides research insights to help investors make informed choices.
How do I track mutual fund performance on KSquare?
KSquare offers a dashboard where you can view real-time NAV, portfolio value, returns, and performance trends.